Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05958082 · ClinicalTrials.gov registry record · NA

Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer

A NA study of Prostate Cancer, sponsored by Henry Ford Health System.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05958082 is a NA study of Prostate Cancer that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 50 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05958082, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Henry Ford Health System.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study to improve rates of germline genetic testing for black patients with aggressive prostate cancer as recommended by the updated guidelines by the National Cancer Comprehensive Network (NCCN) in 2018. In this study, consented patients will undergo a low-risk intervention of an educational session with a trained staff member on germline testing in prostate cancer and, if agreeable, subsequent germline cancer genetic testing via a commercial lab test.

Conditions Studied

Prostate Cancer

Interventions

  • BEHAVIORAL Educational video

Study Locations (1)

Michigan

  • Henry Ford Cancer Pavilion - Detroit

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-01-01
Est. Completion 2026-12
Phase NA

Sponsor

Henry Ford Health System

234 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05958082

The ClinicalTrials.gov registry entry for NCT05958082 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Educational video is the first listed.

NCT05958082 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05958082 about?

NCT05958082 is a clinical study titled "Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer". This is a pilot study to improve rates of germline genetic testing for black patients with aggressive prostate cancer as recommended by the updated guidelines by the National Cancer Comprehensive Network (NCCN) in 2018. In this study, consented patients will undergo a low-risk intervention of an ed...

What is the current status of trial NCT05958082?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-01-01. Estimated completion is 2026-12.

What conditions does trial NCT05958082 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT05958082?

The interventions under investigation include: Educational video (BEHAVIORAL).

Who is sponsoring clinical trial NCT05958082?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05958082 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.